May 27,2022

Researchers Use AI to Predict Cancer Risk of Lung Nodules

An artificial intelligence (AI) tool helps doctors predict the cancer risk in lung nodules seen on CT, according to a new study published in the journal Radiology. Pulmonary nodules appear as small spots on the lungs on chest imaging. They have become a much more common finding as CT has gained favor over X-rays for chest imaging.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
May 03,2022

Oulu University Hospital Expands Partnership with Siemens Healthineers for Better Healthcare in Northern Finland

Siemens Healthineers and Oulu University Hospital in Finland have entered a strategic partnership for the next ten years, adding to an existing radiotherapy collaboration to jointly expand and modernize the radiology department. This Value Partnership includes the supply, installation, and maintenance of medical imaging technology and software, training and further education of staff, a flexible financing concept and consulting services to increase process efficiency and improve the value chain of clinical care.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
May 03,2022

FDA clears iSono’s automated, wearable 3D breast ultrasound system

iSono Health announced today that the FDA cleared its Atusa system for whole-breast ultrasound imaging. South San Francisco, California–based iSono designed Atusa as a first-of-its-kind, compact, automated whole-breast ultrasound system with a unique wearable accessory and intuitive software for automated image acquisition and analysis.

REGULATORY FDA
View Analyst & Ambassador Comments
Go to original news
May 03,2022

Molecular Diagnostics Market worth $30.2 billion by 2027

According to the new market research report "Molecular Diagnostics Market by Product & Service (Reagents, Kits, Instruments), Test Type (Lab, PoC), Technology (PCR, INAAT, NGS, ISH), Application (Infectious, Oncology, Genetic Testing), End User (Diagnostic Labs, Hospitals) - Global Forecast to 2027", published by MarketsandMarkets™, the global market is valued at an estimated USD 23.2 billion in 2022 and is projected to reach USD 30.2 billion by 2027, at a CAGR of 5.4%.

View Analyst & Ambassador Comments
Go to original news
May 04,2022

Sidekick Health grabs $55M for digital-first care programs

Iceland’s Sidekick Health has developed a gamified digital care platform that’s designed to support healthcare outcomes by applying personalized behavioral lifestyle nudges, including alongside clinical treatments like drugs, to augment, extend and support patient care for a range of chronic diseases and conditions from cancer to cardiovascular health, diabetes and arthritis — a formula that’s now scored it $55 million in Series B growth funding. The new round is led by London-based VC firm Novator Ventures, with participation from Wellington Partners, Asabys Partners and Frumtak Ventures, as well as a U.S.-based strategic investor which it’s not disclosing yet but says will be revealed at a later stage.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 09,2022

Oncological digital therapeutics company Fosanis raises more than $10.5M

Fosanis announced today that it closed a Series A funding round worth more than $10.5 million (€10 million). Berlin, Germany-based Fosanis, which develops prescription digital therapeutics for all oncological indications, picked up investments from existing shareholder Ananada Impact Ventures, as well as new investors Debiopharm Innovation Fund, Ship2B Ventures and Equity Pitcher.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
May 13,2022

Ontada Research Highlights Power of Real-World Oncology Data at ISPOR 2022

Ontada®, a McKesson business focused on provider technology and actionable real-world research, education and evidence in oncology, announced the acceptance of seven abstracts for presentation at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The leading global conference for health economics and outcomes research, ISPOR 2022 will take place in Washington, D.C., and virtually from May 15-18, 2022.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
May 13,2022

DermaSensor wins MedTech Innovator Mid-Stage Companies Pitch Event

DermaSensor Inc. — the creator of a handheld, point-and-click device to quickly assess skin lesions for cancer risk — is the winner of the MedTech Innovator Mid-Stage Companies Pitch Event.

PRODUCT

#connected device

View Analyst & Ambassador Comments
Go to original news
May 19,2022

OncoRes Medical raises another $12.5M

OncoRes Medical announced that it raised $12.5 million for its handheld imaging device for identifying cancer cells. Perth, Western Australia-based OncoRes designed its imaging system to facilitate real-time tumor assessment, helping surgeons more accurately identify and remove cancerous tissue, including for breast cancer.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
May 19,2022

Exploring supportive care and information needs through a proposed eHealth application among melanoma patients undergoing systemic therapy: a qualitative study

During and after systemic therapy, patients with high risk and advanced melanoma experience challenges regarding cancer-related symptoms, treatment-related adverse events, and an impact of these symptoms on their physical and psychosocial well-being. Few studies have investigated the specific needs of these patients and the potential role of eHealth applications in meeting those needs.

CLINICAL STUDY

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY